Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
45 hedge funds and large institutions have $136M invested in Applied Therapeutics in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,150% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 2
750% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 2
417% more capital invested
Capital invested by funds: $26.3M → $136M (+$110M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more funds holding
Funds holding: 30 → 45 (+15)
15.09% more ownership
Funds ownership: 14.05% → 29.14% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$16.9M |
| 2 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
+$6.86M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.22M |
| 4 |
BlackRock
New York
|
+$4.52M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$3.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.23M |
| 2 |
Millennium Management
New York
|
-$288K |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$123K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
APLT Hedge Fund Activity: Q4 2019 in Review
45 of the 5,093 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q4 2019, worth a combined $136M — up 417% from $26.3M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new APLT positions and 2 closed out — a net gain of 15 holders — while 25 added to existing stakes and 2 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $16.9M. The largest seller was Fidelity Investments, cutting an estimated $5.23M.
- 45 institutional investors held Applied Therapeutics (APLT) as of Q4 2019, up from 30 in Q3 2019.
- Funds reported $136M of Applied Therapeutics stock for Q4 2019, up 417% quarter-over-quarter.
- 17 funds opened new Applied Therapeutics positions in Q4 2019 and 2 closed out, a net change of +15 holders.
- The largest Applied Therapeutics buyer in Q4 2019 was OrbiMed, an estimated $16.9M added.
- The largest Applied Therapeutics seller in Q4 2019 was Fidelity Investments, an estimated $5.23M sold.
Based on aggregated 13F filings for Q4 2019.